SCD and Alzheimer disease: Interestingly, dysregulation in levels of monounsaturated fatty acids (MUFA) have emerged in studies of AD and other neurodegenerative diseases, with remarkably beneficial effects found by lowering activity of Stearoyl-CoA desaturase (SCD), the rate limiting enzyme in MUFA synthesis15,18–26.